DK0711289T3 - Piperazinforbindelser til anvendelse i terapi - Google Patents

Piperazinforbindelser til anvendelse i terapi

Info

Publication number
DK0711289T3
DK0711289T3 DK94921756T DK94921756T DK0711289T3 DK 0711289 T3 DK0711289 T3 DK 0711289T3 DK 94921756 T DK94921756 T DK 94921756T DK 94921756 T DK94921756 T DK 94921756T DK 0711289 T3 DK0711289 T3 DK 0711289T3
Authority
DK
Denmark
Prior art keywords
utility
compounds
receptors
piperazine compounds
depression
Prior art date
Application number
DK94921756T
Other languages
Danish (da)
English (en)
Inventor
Kwen-Jen Chang
Michael Joseph Bishop
Dulce Garrido Bubacz
Nutt Robert Walton Mc Jr
Original Assignee
Delta Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Pharmaceuticals Inc filed Critical Delta Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0711289T3 publication Critical patent/DK0711289T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Water Treatment By Sorption (AREA)
DK94921756T 1993-07-30 1994-07-29 Piperazinforbindelser til anvendelse i terapi DK0711289T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9833393A 1993-07-30 1993-07-30
US16987993A 1993-12-17 1993-12-17
PCT/GB1994/001641 WO1995004051A1 (en) 1993-07-30 1994-07-29 Piperazine compounds used in therapy

Publications (1)

Publication Number Publication Date
DK0711289T3 true DK0711289T3 (da) 2000-11-06

Family

ID=26794651

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94921756T DK0711289T3 (da) 1993-07-30 1994-07-29 Piperazinforbindelser til anvendelse i terapi

Country Status (18)

Country Link
US (1) US5552404A (de)
EP (1) EP0711289B1 (de)
JP (1) JPH09501156A (de)
CN (1) CN1054850C (de)
AT (1) ATE195733T1 (de)
AU (1) AU692788B2 (de)
CA (1) CA2168432C (de)
DE (1) DE69425662T2 (de)
DK (1) DK0711289T3 (de)
ES (1) ES2149881T3 (de)
GR (1) GR3034695T3 (de)
HU (1) HU221726B1 (de)
IL (1) IL110512A (de)
MY (1) MY111348A (de)
PT (1) PT711289E (de)
RU (1) RU2133744C1 (de)
TW (1) TW386081B (de)
WO (1) WO1995004051A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985880A (en) 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
US5681830A (en) * 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
US5807858A (en) * 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
US6046200A (en) * 1994-09-09 2000-04-04 The United States Of America As Represented By The Secretary Of The Army Compositions having neuroprotective and analgesic activity
US6410537B1 (en) * 1994-09-09 2002-06-25 The United States Of America As Represented By The Secretary Of The Army Compositions having neuroprotective and analgesic activity
SE9504662D0 (sv) * 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9504661D0 (sv) * 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
GB9709972D0 (en) * 1997-05-19 1997-07-09 Pfizer Ltd Tetrazoles
GB9804734D0 (en) * 1998-03-05 1998-04-29 Pfizer Ltd Compounds
US6359111B1 (en) 1998-05-28 2002-03-19 Neorx Corporation Opioid receptor targeting
AU4572999A (en) 1998-06-18 2000-01-05 Sepracor, Inc. Tetrapeptides, analogs and peptidomimetics which bind selectively mammalian opioid receptors
SE9904673D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904674D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
WO2001070684A2 (en) * 2000-03-16 2001-09-27 Sepracor, Inc. Peptidomimetic ligands for cellular receptors and ion channels
SE0001209D0 (sv) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
SE0100764D0 (sv) * 2001-03-07 2001-03-07 Astrazeneca Ab New assymetric process
WO2002080918A1 (fr) * 2001-04-02 2002-10-17 Toray Industries, Inc. Agent therapeutique ou prophylactique en cas de miction frequente ou d'incontinence urinaire
KR100885100B1 (ko) 2001-05-18 2009-02-20 아스트라제네카 아베 4(페닐-피페라지닐-메틸)벤즈아미드 유도체 및 통증,불안증 또는 위장관 장애 치료를 위한 이들의 용도
CN1596113B (zh) * 2001-10-29 2010-05-26 蒙特库克生物科学公司 δ受体激动剂化合物在制备治疗抑郁症的药物中的应用
EP1469850B1 (de) * 2002-01-02 2013-01-02 Versi Group, LLC Verfahren zur behandlung von sexuellen funktionsstörungen mit delta opioid-rezeptor-agonist-verbindungen
US6881829B2 (en) * 2002-04-26 2005-04-19 Chimeracom, L.L.C. Chimeric hybrid analgesics
US8476280B2 (en) * 2002-05-09 2013-07-02 Versi Group, Llc Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
EP1505976B1 (de) 2002-05-16 2007-12-12 N.V. Organon Synergistische kombination eines opiatanalgetikums und eines nsaid
CN1202843C (zh) * 2002-06-21 2005-05-25 天大药业(深圳)有限公司 一种戒毒药物组合物及其制备方法和应用
CN1288158C (zh) * 2002-07-11 2006-12-06 东丽株式会社 用于预防恶心和呕吐的治疗剂或预防剂
US20050241431A1 (en) * 2002-09-27 2005-11-03 Continental Teves Ag & Co. Ohg Adjustable pedal device
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
US7314880B2 (en) * 2003-01-02 2008-01-01 Mount Cook Biosciences, Inc. Cardioprotective delta opioid receptor agonists and methods of using same
US20050026879A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20090297611A1 (en) * 2003-07-31 2009-12-03 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease
TWI317286B (en) 2003-12-31 2009-11-21 Targeting delivery system
DK1781631T3 (da) 2004-08-02 2012-05-14 Astrazeneca Ab Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf
AU2006236622B2 (en) * 2005-04-14 2011-09-22 Versi Group Llc Compositions of novel opioid compounds and method of use thereof
JP2010504359A (ja) 2006-09-20 2010-02-12 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 局部麻酔および／または疼痛緩和のための、揮発性麻酔剤を送達するための方法
CN102014961B (zh) 2008-01-22 2017-10-13 得克萨斯大学体系董事会 用于局部麻醉和/或疼痛缓解的含有萃取溶剂的挥发性麻醉剂组合物
KR20110018317A (ko) * 2008-05-20 2011-02-23 아스트라제네카 아베 불안성 주요 우울 장애의 치료 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2630435A (en) * 1948-09-09 1953-03-03 Burroughs Wellcome Co N-benzohydryl-n-methyl piperazines and process of preparing same
US4518711A (en) 1983-05-16 1985-05-21 Gibson-Stephens Institute Conformationally constrained cyclic enkephalin analogs with delta receptor specificity
GB8320701D0 (en) 1983-08-01 1983-09-01 Wellcome Found Chemotherapeutic agent
IL78939A (en) 1986-01-17 1990-04-29 Robins Co Inc A H Pharmaceutical compositions containing n-substituted arylalkyl-and arylalkylene-piperidines and tetrahydropyridines and certain such novel compounds
IL86061A (en) * 1987-04-16 1992-07-15 Lilly Co Eli Derivatives of trans-3,4-isomer of 4-methyl-4-phenyl-piperidines,process for their preparation and pharmaceutical compositions containing them
US4816586A (en) 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
DE69003200T2 (de) * 1989-06-19 1994-01-20 Wellcome Found Arylsubstituierte Aminderivate verwendbar in der Krebstherapie.
EP0458160A3 (en) 1990-05-25 1992-03-18 Sociedad Espanola De Especialidades Farmaco-Terapeuticas, S.A. Substituted diphenylmethane derivatives as analgesic or anti-inflammatory agents
SE467304B (sv) * 1990-10-31 1992-06-29 Kamewa Ab Styr- och reverseringsanordning foer ett marint straaldriftsaggregat
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
NZ240863A (en) * 1991-09-11 1995-04-27 Mcneilab Inc Substituted 4-aryl piperidine and 4-aryl piperazine derivatives, preparation and pharmaceutical compositions thereof
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds

Also Published As

Publication number Publication date
GR3034695T3 (en) 2001-01-31
EP0711289B1 (de) 2000-08-23
CA2168432A1 (en) 1995-02-09
JPH09501156A (ja) 1997-02-04
HU9501982D0 (en) 1995-09-28
EP0711289A1 (de) 1996-05-15
CN1133593A (zh) 1996-10-16
IL110512A (en) 1998-10-30
IL110512A0 (en) 1994-10-21
ATE195733T1 (de) 2000-09-15
ES2149881T3 (es) 2000-11-16
CN1054850C (zh) 2000-07-26
HUT72893A (en) 1996-06-28
DE69425662D1 (de) 2000-09-28
MY111348A (en) 1999-11-30
AU7235194A (en) 1995-02-28
CA2168432C (en) 2004-03-23
US5552404A (en) 1996-09-03
AU692788B2 (en) 1998-06-18
RU2133744C1 (ru) 1999-07-27
DE69425662T2 (de) 2001-04-12
WO1995004051A1 (en) 1995-02-09
TW386081B (en) 2000-04-01
HU221726B1 (hu) 2002-12-28
PT711289E (pt) 2001-02-28

Similar Documents

Publication Publication Date Title
DK0711289T3 (da) Piperazinforbindelser til anvendelse i terapi
CA2129046A1 (en) Opioid diarylmethylpiperazines and piperidines
ATE222754T1 (de) Ultrafeines pulver zur inhalation und dessen herstellung
ZA955868B (en) Substituted pyrimidine compounds and the use thereof
DE69207526D1 (de) Tramadol N-Oxid, dessen Enantiomere und Zusammensetzungen davon, und deren Verwendung
DE69707461T2 (de) Titandioxidteilchen, ihr herstellungsverfahren und ihre verwendung in kosmetika und lacken
TR200000726T2 (tr) Budesonid ve formoterol'ün yeni kullanımı.
GEP20074165B (en) Imidazolopyridines and methods of making and using the same
ZA951780B (en) Prodrugs of morpholine tachykinin receptor antagonists
ZA200409814B (en) 3-Z-(1-(4-(N-((4-methyl-piperazin-1-YL)-methylcarbnonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene)-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition.
DE69531038D1 (de) Adsorptionskörper enthaltend Aktivkohle, aktiviertes Aluminiumoxid und einen anorganischen Binder und Methode zu dessen Herstellung
ATE163042T1 (de) Lactobazillusstämme menschlichen ursprungs, ihre zusammensetzung und deren verwendung
MXPA06000716A (es) Derivados de quinolina y quinazolina que tienen afinidad hacia receptores del tipo 5ht1.
IL139080A0 (en) Btx inhibitors and methods for their indentification and use
DE60202624D1 (de) Schmierbeständiger, aus nanoverbundmaterial bestehender hartüberzug und methode zu seiner herstellung
ATE352300T1 (de) Zusammensetzung bestehend aus phentolaminmesylat und deren verwendung
EP1401960A4 (de) Kohlenteer-und kohlenwasserstoffmischpech und verfahren und verwendung davon
MY128639A (en) 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
ATE322288T1 (de) Zusammensetzungen zur immunisierung sowie deren verwendung
GEP20074125B (en) Pyrazolopyridines and methods of making and using the same
MXPA04004477A (es) Antagonistas del neuropeptido neuroquinina-1(nk1).
NZ335052A (en) Piperazino derivatives as neurokinin antagonists
DE69918540D1 (de) Torsionsschraubenfeder
ATE414734T1 (de) Russe und deren verwendung
TW200505827A (en) Process for the distillation of a mixture of isomeric diisocyanatodiphenylmethanes